Sweden· SE-20250402000069
Raxeva 2,5 mg/50 mg Kapsel, hård
A medicinal product containing acetylsalicylic acid + rivaroxaban, registered in Sweden by PharOS - Pharmaceutical Oriented Services Ltd.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Acetylsalicylic Acid + Rivaroxaban
- Manufacturer
- PharOS - Pharmaceutical Oriented Services Ltd
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20250402000069
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acetylsalicylic acid + rivaroxaban in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRIVAROXABAN/ACETYLSALICYLIC ACID SANDOZSandoz s.r.o., Praha
- GermanyRivaroxaass ApontisZentiva Pharma Gmbh
- PolandRunaplax + ASASandoz Polska Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Runaplax Ass, Xanirva Duo
- Czechia · Xanirva Duo
- Germany · Rivaroxaass Apontis
- France · Trovunex
- Croatia · Hypolivat
- Hungary · Rivaroxaban/Asa Sandoz, Xavipiran
- Italy · Rivaroxaban E Acido Acetilsalicilico Doc
- Malta · Raxeva, Rivaroxaban/Acetylsalicylic Acid Pharos
- Portugal · Xanirva Duo
- Romania · Xanirva Duo
- Slovenia · Runaplax Combo
- Slovakia · Rivaroxaban/Acetylsalicylic Acid Sandoz, Xanirva Duo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f711f2ef-2159-40f7-b64f-1a8f04d82253 GET /v1/drugs/f711f2ef-2159-40f7-b64f-1a8f04d82253?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"sPAR",
"PAR",
"sRMP"
],
"se_npl_id": "20250402000069",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20250402000069",
"product_doc_link": "https://docetp.mpa.se/LMF/Raxeva%20capsule%2C%20hard%20ENG%20SmPC_09001bee84e85d8a.pdf"
}See everything about acetylsalicylic acid + rivaroxaban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.